Therapy for Psychiatric Disorders Down Substance Abuse Later

Providing treatment for pediatric patients with psychiatric disorders do not raise the risk of developing substance use, misuse, or substance use disorder (SUD) later in life.

For ADHD, major depressive disorder (MDD), and psychotic disorders, treatment with medication reduced the risk of developing a SUD. The study is published in the Journal of Child and Adolescent Psychopharmacology.

‘Earlier initiation and longer treatment play a vital role in reducing the risk of substance use disorders.’
Read More..

Tweet it Now

“We have known that pediatric mental illness in children doubles to triples the likelihood to develop a substance use problem,” says Wilens, prompting his team to explore if this is true if these disorders are medically treated in children. Or does treating psychiatric disorders with medication actually mitigate the risk for ultimate substance use?

Research of Treating Mental Illness

The research team examined 26 prior studies with long-term results, 21 focused on ADHD, 2 on MDD, and 3 on the psychotic disorder, to find the answer. They found no studies examining the impact of pharmacotherapy on the development of substance use for children or adolescents with anxiety, conduct disorder, personality disorder, and post-traumatic stress disorder.

“We found that pharmacological treatments for psychiatric disorders during childhood appear to reduce the development of SUD by about 30-35%, especially when treatment is initiated early and for longer durations, particularly with ADHD,” explains co-author Amy Berger, a research coordinator in the Division of Child and Adolescent Psychiatry.

Positive results also trended for MDD. They were not able to make conclusions about reduced substance use after treatment of bipolar disorder due to the limited literature.

Drug Abuse | Drug Addiction | Substance Abuse - Overview
The use of Drugs for reasons other than its prescribed recommendation, is known as Drug abuse or substance abuse. Drug abuse or substance abuse is initiated by various biological and social factors.

“The treatments that began before the age of nine, and were more ongoing, were the most effective at reducing SUD, especially in ADHD,” says Wilens, adding that it makes intuitive sense that earlier and longer treatment has a much better and larger impact down the line. “And we think that it is probably pertinent to other psychiatric disorders.”

In related research, for the past two years, Wilens and his team have been conducting another NIH-funded study through the HEAL Initiative exploring the impact of treating psychiatric conditions in 16- to-30-year-old patients on the development of substance use disorders, particularly opioid use disorder.

“The fact that the literature shows that juvenile-onset psychiatric disorders are significant risk factors for SUD coupled with our findings that medication treatment reduces that risk affirms that we need to identify and treat psychiatric disorders early in life,” adds Wilens.

“Picking it up early and treating these kids as long as they require treatment leads to a much better outcome when it comes to substance use disorders.”

Source-Medindia